NASDAQ: LUCD
Lucid Diagnostics Inc Stock Ownership - Who owns Lucid Diagnostics?

Insider buying vs selling

Have Lucid Diagnostics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Dennis MatheisDirector2026-05-20245,000$1.00
$245.24kBuy
Dennis MatheisDirector2025-08-20100,000$1.02
$101.80kBuy

1 of 1

LUCD insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LUCD insiders and whales buy or sell their stock.

LUCD Shareholders

What type of owners hold Lucid Diagnostics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Pavmed Inc15.41%31,302,444$30.08MInsider
Blackrock Inc2.28%4,638,243$4.46MInstitution
Vanguard Capital Management LLC2.05%4,154,770$3.99MInstitution
Masters Capital Management LLC1.97%4,000,000$3.84MInstitution
Aberdeen Group PLC1.79%3,644,277$3.50MInstitution
Lishan Aklog1.79%3,636,627$3.49MInsider
Two Seas Capital LP1.48%3,000,000$2.88MInstitution
Geode Capital Management LLC1.11%2,245,350$2.16MInstitution
Dennis M. McGrath0.89%1,813,569$1.74MInsider
Russell Investments Group Ltd0.78%1,583,608$1.52MInstitution

1 of 3

LUCD vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LUCD17.54%21.14%Net BuyingNet Buying
RXST74.94%25.06%Net BuyingNet Buying
ANIK81.56%18.44%Net SellingNet Buying
APYX49.70%21.09%Net Buying
INGN68.57%31.43%Net SellingNet Selling

Lucid Diagnostics Stock Ownership FAQ

Who owns Lucid Diagnostics?

Lucid Diagnostics (NASDAQ: LUCD) is owned by 17.54% institutional shareholders, 21.14% Lucid Diagnostics insiders, and 61.32% retail investors. Pavmed Inc is the largest individual Lucid Diagnostics shareholder, owning 31.30M shares representing 15.41% of the company. Pavmed Inc's Lucid Diagnostics shares are currently valued at $31.30M.

If you're new to stock investing, here's how to buy Lucid Diagnostics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.